Exploring the Need for Sustained GLP-1 Agonist Therapy: a Perspective on Weight Regain After Bariatric Surgery

Obes Surg. 2024 Jun;34(6):2259-2260. doi: 10.1007/s11695-024-07229-x. Epub 2024 Apr 15.
No abstract available

Publication types

  • Editorial
  • Letter

MeSH terms

  • Bariatric Surgery*
  • Glucagon-Like Peptide 1* / agonists
  • Humans
  • Hypoglycemic Agents / therapeutic use
  • Obesity, Morbid* / surgery
  • Weight Gain* / drug effects
  • Weight Loss

Substances

  • Glucagon-Like Peptide 1
  • Hypoglycemic Agents